Variant report
Variant | esv3509263 |
---|---|
Chromosome Location | chr13:39745852-39751850 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
NXT1P1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17444010 | chr13:39745892-39745893 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs573425240 | chr13:39745920-39745921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542792849 | chr13:39745953-39745954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561390428 | chr13:39745962-39745963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs74046313 | chr13:39745966-39745967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4274310 | chr13:39745992-39745993 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs545734442 | chr13:39746000-39746001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs142194924 | chr13:39746023-39746024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs9576742 | chr13:39746085-39746086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530971300 | chr13:39746107-39746108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs117386585 | chr13:39746117-39746118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs2324163 | chr13:39746123-39746124 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs151221262 | chr13:39746124-39746125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs549209485 | chr13:39746155-39746156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs9576743 | chr13:39746178-39746179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9576744 | chr13:39746191-39746192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs188183206 | chr13:39746208-39746209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2324164 | chr13:39746209-39746210 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs371428564 | chr13:39746236-39746237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs373669729 | chr13:39746254-39746255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs9576745 | chr13:39746257-39746258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2324165 | chr13:39746260-39746261 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs112268185 | chr13:39746269-39746270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2324166 | chr13:39746334-39746335 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs556509485 | chr13:39746373-39746374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs573415143 | chr13:39746374-39746375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs553876356 | chr13:39746407-39746408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570439277 | chr13:39746423-39746424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553151702 | chr13:39746439-39746440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7333862 | chr13:39746470-39746471 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs545259707 | chr13:39746481-39746482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565602369 | chr13:39746535-39746536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531085669 | chr13:39746569-39746570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544611429 | chr13:39746570-39746571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140448330 | chr13:39746571-39746572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530220964 | chr13:39746576-39746577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs547162917 | chr13:39746601-39746602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs369681501 | chr13:39746634-39746635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528322795 | chr13:39746663-39746664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs375352388 | chr13:39746665-39746666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs57461704 | chr13:39746666-39746667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs112884256 | chr13:39746668-39746669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551263896 | chr13:39746672-39746673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs571537831 | chr13:39746681-39746682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs78095442 | chr13:39746710-39746711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs181033647 | chr13:39746731-39746732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs185552915 | chr13:39746740-39746741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372927707 | chr13:39746772-39746773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs115674838 | chr13:39746782-39746783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs146493966 | chr13:39746824-39746825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Monoclonal gammopathy of undetermined significance | 19135901 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Melanoma | 18172304 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 17217626 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Mental retardation | 17502991 | CNVD |
Retinoblastoma | 17502991 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Liposarcoma | 21253554 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cervical cancer | 21062161 | CNVD |
microdeletion syndrome | 19284877 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:39739000-39764000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr13:39747600-39748600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr13:39748800-39750200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr13:39749400-39749800 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
5 | chr13:39750800-39751000 | Enhancers | Left Ventricle | heart |